1. Home
  2. AMRX vs DKL Comparison

AMRX vs DKL Comparison

Compare AMRX & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • DKL
  • Stock Information
  • Founded
  • AMRX 2002
  • DKL 2012
  • Country
  • AMRX United States
  • DKL United States
  • Employees
  • AMRX N/A
  • DKL N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • DKL Natural Gas Distribution
  • Sector
  • AMRX Health Care
  • DKL Energy
  • Exchange
  • AMRX Nasdaq
  • DKL Nasdaq
  • Market Cap
  • AMRX 2.3B
  • DKL 2.3B
  • IPO Year
  • AMRX N/A
  • DKL N/A
  • Fundamental
  • Price
  • AMRX $7.32
  • DKL $41.98
  • Analyst Decision
  • AMRX Strong Buy
  • DKL Buy
  • Analyst Count
  • AMRX 4
  • DKL 4
  • Target Price
  • AMRX $11.50
  • DKL $44.25
  • AVG Volume (30 Days)
  • AMRX 1.9M
  • DKL 190.2K
  • Earning Date
  • AMRX 05-02-2025
  • DKL 05-07-2025
  • Dividend Yield
  • AMRX N/A
  • DKL 10.54%
  • EPS Growth
  • AMRX N/A
  • DKL 7.97
  • EPS
  • AMRX N/A
  • DKL 2.98
  • Revenue
  • AMRX $2,830,186,000.00
  • DKL $938,491,000.00
  • Revenue This Year
  • AMRX $10.20
  • DKL $4.01
  • Revenue Next Year
  • AMRX $7.15
  • DKL $4.46
  • P/E Ratio
  • AMRX N/A
  • DKL $14.02
  • Revenue Growth
  • AMRX 13.42
  • DKL N/A
  • 52 Week Low
  • AMRX $6.29
  • DKL $34.59
  • 52 Week High
  • AMRX $9.48
  • DKL $45.71
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 46.61
  • DKL 58.62
  • Support Level
  • AMRX $7.02
  • DKL $40.10
  • Resistance Level
  • AMRX $7.39
  • DKL $42.75
  • Average True Range (ATR)
  • AMRX 0.18
  • DKL 1.01
  • MACD
  • AMRX -0.00
  • DKL 0.16
  • Stochastic Oscillator
  • AMRX 45.80
  • DKL 83.70

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests

Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.

Share on Social Networks: